icon-folder.gif   Conference Reports for NATAP  
 
  EASL 45th Annual Meeting
April 14-18, 2010
Vienna, Austria		 Back grey_arrow_rt.gif
 
 
 
In Vitro Antiviral Activity of IDX320, a Novel and Potent Macrocyclic HCV Protease Inhibitor
 
 
  Reported by Jules Levin
EASL Apr 14-18 201 Vienna Astria
 
Idenix Pharma